Information;Judgment — ECLI:EU:T:2021:656
Date: 2021-10-06
Language of the case: English
Court formation: Third Chamber
Subject matter: Trade marks;Intellectual, industrial and commercial property
Procedure: Action for annulment - unfounded

Judgment of the General Court (Third Chamber) of 6 October 2021 – Dermavita Company v EUIPO – Allergan Holdings France (JUVÉDERM VYBRANCE) (Case T‑635/20) (EU trade mark – Invalidity proceedings – EU word mark JUVÉDERM VYBRANCE – Late payment of the appeal fee – Inadmissibility of the appeal before the Board of Appeal – Article 101(4) of Regulation (EU) 2017/1001 – Article 106(1)(b) of Regulation 2017/1001 – Restitutio in integrum) 1. EU trade mark – Procedural provisions – Restitutio in integrum – Applicability to the prescribed time limit for paying appeal fees (European Parliament and Council Regulation 2017/1001, Arts 68, 104(5) and 105(1) and (2)) (see para. 35) 2. EU trade mark – Decisions of the Office – No obligation to inform the parties of the judicial remedies available and of the time limits (European Parliament and Council Regulation 2017/1001, Arts 68 and 104; Commission Regulation No 2018/625, Art. 68) (see para. 36) Re: Action brought against the decision of the Fourth Board of Appeal of EUIPO of 24 August 2020 (Case R 1014/2020-4), relating to invalidity proceedings between Dermavita Company and Allergan Holdings France. Operative part The Court: 1. Dismisses the action; 2. Orders Dermavita Company S.a.r.l. to pay the costs.